People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Exela Holdings Inc | — | Pharmaceuticals | Series B | $26.4M | $556.0M | 2021 |
Robert Funsten at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Funsten on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Collier | 1 | 8 |
| Thomas Baruch | 1 | 4 |
| Padmavathi Koneru | 1 | 1 |
| Phanesh Koneru | 1 | 1 |
| Murali Krishna Reddy Adala | 1 | 1 |
| Frank Krishna Reddy Wright | 1 | 1 |
| Frank Wright | 1 | 1 |
| Thomas Krishna Reddy Baruch | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.